Submitted by Anonymous (not verified) on 16 October 2023 - 13:52
Human medicines European public assessment report (EPAR): Bemrist Breezhaler, indacaterol,mometasone, Asthma, Date of authorisation: 30/05/2020, Revision: 6, Status: Authorised
Source: